GDPR represents an “urgent threat” to the EU’s research lead...

More than 5,000 collaborative studies were thwarted by GDPR rules in 2019 – but is there a way to protect sensitive data while still allowing international health research to thrive? <

Digitalising drug discovery

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is ver

Unlocking health data to improve oncology outcomes

As the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial health data and real-world evidence (RWE) environment.

Oxford Uni spin-out Zegami seeks NHS X-rays for COVID-19 dia...

Optimising health data in the UK

Maximising the UK’s potential as a leader in health data “is non-negotiable” – but how do we do so within the framework of disparate sources and multiple accountable organisations, all whil